Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
- Resource Type
- Article
- Authors
- Deng, Li-Juan; Zhou, Ke-Shu; Liu, Li-Hong; Zhang, Ming-Zhi; Li, Zhi-Ming; Ji, Chun-Yan; Xu, Wei; Liu, Ting; Xu, Bing; Wang, Xin; Gao, Su-Jun; Zhang, Hui-Lai; Hu, Yu; Li, Yan; Cheng, Ying; Yang, Hai-Yan; Cao, Jun-Ning; Zhu, Zun-Min; Hu, Jian-Da; Zhang, Wei; Jing, Hong-Mei; Ding, Kai-Yang; Zhang, Xiang-Yang; Zhao, Ren-Bin; Zhang, Bin; Tian, Ya-Min; Song, Yong-Ping; Song, Yu-Qin; Zhu, Jun
- Source
- In Blood Advances 22 August 2023 7(16):4349-4357
- Subject
- Clinical Trials and Observations
Lymphoid Neoplasia
- Language
- ISSN
- 2473-9529